These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 17924565

  • 21. Monoclonal antibody therapy for Crohn's disease.
    Selby W.
    Intern Med J; 2001 Mar; 31(2):73-4. PubMed ID: 11480481
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prolonged duration of response to infliximab in early pediatric Crohn's disease.
    Kugathasan S.
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S40-3. PubMed ID: 11685975
    [No Abstract] [Full Text] [Related]

  • 25. Interstitial pneumonitis after infliximab therapy for Crohn's disease.
    Weatherhead M, Masson S, Bourke SJ, Gunn MC, Burns GP.
    Inflamm Bowel Dis; 2006 May; 12(5):427-8. PubMed ID: 16670533
    [No Abstract] [Full Text] [Related]

  • 26. [Meningitis due to Listeria monocytogenes as a complication of infliximab therapy].
    Joosten AA, van Olffen GH, Hageman G.
    Ned Tijdschr Geneeskd; 2003 Jul 26; 147(30):1470-2. PubMed ID: 12908351
    [Abstract] [Full Text] [Related]

  • 27. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M, Meliez H, Seguy D, Viget N, Cortot A, Colombel JF.
    Inflamm Bowel Dis; 2004 Jul 26; 10(4):436-7. PubMed ID: 15475754
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
    Holtmann M, Wanitschke R, Helisch A, Bartenstein P, Galle PR, Neurath M.
    Z Gastroenterol; 2003 Jan 26; 41(1):11-7. PubMed ID: 12541166
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.
    Bell S, Kamm MA.
    Lancet; 2000 Mar 11; 355(9207):858-60. PubMed ID: 10752696
    [No Abstract] [Full Text] [Related]

  • 37. Babesiosis in a patient on infliximab for Crohn's disease.
    Cullen G, Sands BE, Yajnik V.
    Inflamm Bowel Dis; 2010 Aug 11; 16(8):1269-70. PubMed ID: 19885904
    [No Abstract] [Full Text] [Related]

  • 38. Complications of infliximab therapy in children and adolescents affected by Crohn's disease.
    Diamanti A, Papadatou B, Knafelz D, Gambarara M, Ferretti F, Castro M.
    Am J Gastroenterol; 2003 Dec 11; 98(12):2812-3. PubMed ID: 14687847
    [No Abstract] [Full Text] [Related]

  • 39. Use of infliximab in the treatment of Crohn's disease in children and adolescents.
    Hyams JS.
    J Pediatr Gastroenterol Nutr; 2001 Sep 11; 33 Suppl 1():S36-9. PubMed ID: 11685974
    [No Abstract] [Full Text] [Related]

  • 40. Unusual presentation of tuberculosis after infliximab therapy.
    Magro F, Pereira P, Veloso FT, Carneiro F.
    Inflamm Bowel Dis; 2005 Jan 11; 11(1):82-4. PubMed ID: 15674123
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.